BATES; Darren L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BATES; Darren L..The latest application filed is for "interleukin-2 muteins for the expansion of t-regulatory cells".

Company Profile

4.4.9

BATES; Darren L. - Oak Park CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Interleukin-2 Muteins For The Expansion Of T-regulatory Cells App 20220289807 - BATES; Darren L. ; et al.	2022-09-15
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In Combination With Glp-1 Agonists App 20220025059 - YIE; Junming ; et al.	2022-01-27
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists Grant 11,046,774 - Yie , et al. June 29, 2	2021-06-29
Method of producing th9 t-cells App 20210188932 - Garcia; K. Christopher ; et al.	2021-06-24
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In Combination With Glp-1 Agonists App 20210087286 - BATES; Darren L. ; et al.	2021-03-25
Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities Grant 10,738,096 - Garcia , et al. A	2020-08-11
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In App 20190276546 - Yie; Junming ; et al.	2019-09-12
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists Grant 10,294,303 - Yie , et al.	2019-05-21
Superkines And Synthekines: Repurposed Cytokines With New And Enhanced Signaling Activities App 20180016316 - Garcia; K. Christopher ; et al.	2018-01-18
Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (gipr) In Combination With Glp-1 Agonists App 20170275370 - YIE; Junming ; et al.	2017-09-28
Superkines and synthekines: repurposed cytokines with new and enhanced signaling activities Grant 9,738,696 - Garcia , et al. August 22, 2	2017-08-22
Superkines And Synthekines: Repurposed Cytokines With New And Enhanced Signaling Activities App 20160244499 - GARCIA; K. Christopher ; et al.	2016-08-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.